Table 2 Portions of the concepts per group within the three use cases that could be mapped to ELGA template elements (total mappings versus mappings to structured elements)
Concepts in group | Concepts mapped | Concepts mapped to structured elements | |
|---|---|---|---|
Feasibility checking | |||
Demographics | 5 | 5 (100%) | 5 (100%) |
Medical history | 8 | 7 (88%) | 4 (50%) |
Diagnosis | 4 | 3 (75%) | 3 (75%) |
Procedure | 3 | 1 (33%) | 0 (0%) |
Findings | 7 | 7 (100%) | 7 (100%) |
Laboratory findings | 41 | 41 (100%) | 41 (100%) |
Medication | 7 | 7 (100%) | 7 (100%) |
Patient identif. / recruitment | |||
Demographics | 5 | 5 (100%) | 5 (100%) |
Medical history | 10 | 7 (70%) | 4 (40%) |
Medical device | 1 | 1 (100%) | 0 (0%) |
Diagnosis | 5 | 4 (80%) | 4 (80%) |
Procedure | 3 | 1 (33%) | 0 (0%) |
Findings | 25 | 18 (72%) | 16 (64%) |
Laboratory findings | 81 | 81 (100%) | 81 (100%) |
Medication | 9 | 8 (89%) | 8 (89%) |
Scores & classification | 9 | 9 (100%) | 0 (0%) |
Patient characteristics | 1 | 1 (100%) | 1 (100%) |
Trial execution | |||
Demographics | 4 | 2 (50%) | 2 (50%) |
ECG | 9 | 0 (0%) | 0 (0%) |
Adverse events | 11 | 5 (45%) | 5 (45%) |
Medical history | 4 | 4 (100%) | 1 (25%) |
Disease characteristics | 2 | 2 (100%) | 2 (100%) |
Disposition | 2 | 0 (0%) | 0 (0%) |
Patient reported outcome | 3 | 2 (67%) | 0 (0%) |
Vital signs | 8 | 8 (100%) | 7 (88%) |
Laboratory | 57 | 57 (100%) | 57 (100%) |
Lab data | 6 | 6 (100%) | 4 (67%) |
Concomitant medication | 9 | 8 (89%) | 8 (89%) |
Surgery | 5 | 4 (80%) | 0 (0%) |
Substance use | 8 | 8 (100%) | 0 (0%) |
Tumor resp. | 5 | 3 (60%) | 3 (60%) |